Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VIJOURNAL OF PEDIATRICSIF3.52019-02-0152OAAI
Very early treatment for infantile-onset Pompe disease contributes to better outcomes: 10-year experience of nationwide NBS in TaiwanMOLECULAR GENETICS AND METABOLISMIF3.52019-02-010PREAI
Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in TaiwanORPHANET JOURNAL OF RARE DISEASESIF3.52018-05-2552OAAI
Functional and biological studies of alpha galactosidase A variants with uncertain significance from newborn screening in TaiwanMOLECULAR GENETICS AND METABOLISMIF3.52018-02-010PREAI
Very early treatment for infantile-onset Pompe disease contributes to better outcomes: 10-year experience of nationwide NBS in TaiwanMOLECULAR GENETICS AND METABOLISMIF3.52018-02-010PREAI
Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe DiseaseCLINICAL CHEMISTRYIF6.32017-07-0129OAAI
Pathogenetic studies of 13 novel missense mutations in α-galactosidase A from the newborn screening in TaiwanMOLECULAR GENETICS AND METABOLISMIF3.52015-02-010PREAI
Evaluation of plasma globotriaosylsphingosine (LysoGb3) in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4+919G A)MOLECULAR GENETICS AND METABOLISMIF3.52013-02-010PREAI
Obesity and clustering of cardiovascular disease risk factors are associated with elevated plasma complement C3 in children and adolescentsPEDIATRIC DIABETESIF5.62012-04-0514OAAI
Birth weight and type 1 diabetes among schoolchildren in Taiwan - A population-based case-controlled studyDIABETES RESEARCH AND CLINICAL PRACTICEIF7.42006-12-0118PREAI
Childhood diabetes identified in mass urine screening program in Taiwan, 1993-1999DIABETES RESEARCH AND CLINICAL PRACTICEIF7.42003-03-0128PREAI
Low birth weight and high birth infants are both at an increased risk to have type 2 diabetes among schoolchildren in TaiwanDIABETES CAREIF16.62003-02-01248OAAI